Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026
Sanofi SA (NASDAQ:SNY) is one of the best cheap stocks to buy for 2026.
Sanofi Aventis (SNY)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arjuna Capital Farnum Brown And Adam Seitchik | 56,027 | $2,715,069 | +4% | 0.67% |
| 2. | Bailard Inc Thomas Bailard | 26,942 | $1,305,609 | -1% | 0.03% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,042,341 | $99,118,795 | 0.53% | |
| 2. | 1,500,255 | $72,702,357 | 1.27% | |
| 3. | 1,222,003 | $59,218,266 | 0.01% | |
| 4. | 636,141 | $30,827,393 | 3.72% | |
| 5. | 624,011 | $30,170,932 | 0.03% |
News See All
15 Best Cheap Stocks to Buy for 2026
Investors might feel like they have been overwhelmed by the news over the past year. But the stock market keeps reaching for new peaks every trading week.
Sanofi (NASDAQ:SNY) Q4 2025 Earnings Call Transcript
Thomas Larsen: Hello, everyone, this Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q4 and Full Year 2025 Conference Call for investors and analysts.
10 Most Undervalued Foreign Stocks to Buy According to Analysts
On January 1, Todd Gordon from Inside Edge Capital appeared on CNBC to discuss the state of global markets. Todd said that he plans to add global assets to his portfolio in 2026.
Sanofi (SNY) Secures Approval for Cablivi in the US and Plozasiran in China
Sanofi (NASDAQ:SNY) is one of the best blue-chip stocks to buy for 2026. On January 5, the US Food and Drug Administration announced the approval of Sanofi SA (NASDAQ:SNY)’s Cablivi.
10 Best Blue Chip Stocks to Buy for 2026
Blue-chip stocks are set to dominate the pace and direction of the US equity market.
Does Sanofi (SNY) Have a Long Runway for Future Growth?
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Select Fund” fourth-quarter 2025 investor letter.
Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to ‘Equal Weight’ with EUR 85 PT
On January 6, 2026, Barclays downgraded Sanofi (NASDAQ:SNY) from ‘Overweight’ to ‘Equal Weight’, while setting an EUR 85 price target.
11 Most Undervalued Blue Chip Stocks to Buy Now
As we enter 2026, U.S. equities are expected to enter a phase marked by several complexities following the outsized gains in 2025.
Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang
Sanofi (NASDAQ:SNY) is among the ridiculously cheap stocks to buy now. On December 28, Jefferies reiterated its ‘Buy’ rating on Sanofi (NASDAQ:SNY) with an unchanged price target of €100.
Hedge Fund Resource Center Billionaire Hedge Funds
